VIB is a world-class life science research institute in Flanders, Belgium, hosting more than 1800 scientists in over 5 universities. VIB has a long-standing and successful history of translating scientific breakthroughs into impactful societal innovations and new innovative biotech companies.
About the
Engineering Nanobodies for Structural Biology, Molecular Pharmacology and Drug Discovery. We apply Nanobodies in X-ray crystallography and cryo-EM, aiming at the highest-hanging fruits in structural biology. We engineer Nanobodies for applications in biotechnology, molecular pharmacology and drug discovery. We explore new modes of therapeutic intervention and develop first-in-class drugs.
A track record in tech transfer. In 2002, our lab co-founded Ablynx (now a Sanofi company). Ablynx is engaged in the development of proprietary therapeutic Nanobodies. In 2013, we co-founded AgroSafve, now Biotalys. Biotalys employs an Nb-based platform to develop biopesticides for the control of pests and diseases on crops and harvested products. In 2015, we created Confo Therapeutics. Confo Therapeutics employs proprietary Nanobody technology to lock inherent unstable functional conformations of GPCRs as a superior starting point for drug discovery.
Spinning out a new integrated drug discovery company. The Steyaert lab is now spinning out a new integrated drug discovery company based on innovative proprietary applications of Nanobodies, focusing on the discovery and development of novel first-in-class drugs to treat auto-immune diseases and cancer. To strengthen the founding team, we are timely recruiting five junior or senior wet lab-oriented research associates with different expertise profiles. Successful candidates will initially work at the Steyaert lab and join the new company when it moves to our new bio-incubator on the VUB campus Etterbeek (Brussels area).
Your Job
Desirable but not required
We offer